News
News
- Basilea announces Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company for ramucirumab in the ongoing FIDES-03 study with derazantinib in gastric cancer
10/28/2020 / 07:15 - GlobeNewswire - uniQure Announces Third Quarter 2020 Financial Results and Highlights Recent Company Progress
10/27/2020 / 12:05 - GlobeNewswire - Bayer to acquire AskBio for up to $4 billion
10/26/2020 / 09:37 - TeleTrader - Basilea presents preclinical data on anti-angiogenic activity of derazantinib at ENA 2020
10/26/2020 / 07:15 - GlobeNewswire - CRISPR Therapeutics Reports Positive Top-Line Results from Its Phase 1 CARBON Trial of CTX110™ in Relapsed or Refractory CD19+ B-cell Malignancies
10/21/2020 / 13:00 - GlobeNewswire - Roche and Prothena will Advance Prasinezumab into Late-Stage Clinical Development Study in Parkinson’s Disease
10/20/2020 / 22:05 - GlobeNewswire - Vineti Extends Series C Funding Round to $68M with an Expanded Investor Coalition
10/13/2020 / 15:00 - GlobeNewswire - Roche to launch antigen COVID test by end of 2020
10/13/2020 / 09:23 - TeleTrader - Basilea reports interim results from phase 1/2 study FIDES-02 exploring derazantinib in patients with advanced urothelial cancer
10/13/2020 / 07:15 - GlobeNewswire - Basilea reports pooled efficacy data for derazantinib in iCCA patients with FGFR2 gene mutations and amplifications presented at ESMO MAP Virtual Congress 2020
10/12/2020 / 07:15 - GlobeNewswire
Real-time